A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc.
Genmab
Kineta Inc.
Revolution Medicines, Inc.
University Health Network, Toronto
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center